Author Correction: TGF-β promotes pericyte–myofibroblast transition in subretinal fibrosis through the Smad2/3 and Akt/mTOR pathways

Authors

Institutions

Publication Details

Journal
Experimental & Molecular Medicine
Published
2026-06-29
DOI
https://doi.org/10.1038/s12276-026-01786-0
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Author Correction: TGF-β promotes pericyte–myofibroblast transition in subretinal fibrosis through the Smad2/3 and Akt/mTOR pathways

Xueting Luo, Qinghua Qiu, Dawei Luo, Jingfa Zhang et al.
Experimental & Molecular Medicine
Retinal Diseases and Treatments
article

Author Correction: TGF-β promotes pericyte–myofibroblast transition in subretinal fibrosis through the Smad2/3 and Akt/mTOR pathways

Xueting Luo, Qinghua Qiu, Dawei Luo, Jingfa Zhang, Chaoyang Zhang, Yumeng Zhang, Jingting Zhang, Zhenzhen Zhao
article en

Abstract

No abstract available for this paper.
Experimental & Molecular Medicine
Shanghai Jiao Tong University (CN), Shanghai Eye Disease Prevention & Treatment Center (CN), People's Hospital of Shiyan (CN), Shanghai First People's Hospital (CN)
Zero hunger
Openalex Percentile: Top 7%
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.